BRIEF-Amgen, Allergan submit biosimilar biologics license application for ABP 215 to U.S. FDA

* Amgen Inc - BLA submission includes analytical, pharmacokinetic and clinical data, as well as pharmacology and toxicology data
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.